Allicin extracted from Allium sativum shows potent anti-cancer and antioxidant properties in zebrafish - 04/12/23
, Gunimala Chakraborty a, ⁎ 
Abstract |
Garlic (Allium sativum) is an important flavouring component in Indian cuisine. Allicin, a sulphur containing compound, is the most abundant component of garlic and has been widely studied for its antimicrobial and antioxidant properties. It is also known to play a role in the regulation of blood pressure and cholesterol levels. Despite the known health benefits associated with allicin, systematic studies on its anti-cancer properties using animal models are very limited. This study aimed to develop a simple method for the extraction of allicin from fresh garlic, study the stability of the extracted compound at various temperatures, and evaluate the antioxidant, anti-proliferative, pro-apoptotic and anti-angiogenic properties in zebrafish. A five-month stability study indicated that allicin remains significantly stable at temperatures 4 °C and below but shows extensive degradation if stored at room temperature. The in vivo studies in zebrafish using a combination of mutants and transgenic lines demonstrated the antioxidant, anti-proliferative, apoptotic and anti-angiogenic properties of allicin. The study highlights the importance of natural bioactive compounds as potential anti-cancer agents that can be studied further.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | A systematic investigation was carried out to understand the temperature-dependent stability of allicin. |
• | Extracted allicin from fresh garlic remains stable when stored at low temperature for five months. |
• | Toxicity of allicin in zebrafish indicated allicin to be non-toxic even at higher concentrations. |
• | Potent anti-oxidant and anti-angiogenic activity was observed. |
• | Radiation-induced TP53 null mutants treated with allicin showed extensive apoptosis. |
Keywords : Allicin, Fresh garlic, Cancer, Angiogenesis, Apoptosis, Zebrafish
Plan
Vol 169
Article 115854- décembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
